Skip to main content
Clinical Trials/ISRCTN93952605
ISRCTN93952605
Completed
N/A

TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, international normalised ratio (INR) control, and outcome of Treatment with warfarin

Bayer Plc (UK)0 sites200 target enrollmentDecember 18, 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Atrial fibrillation
Sponsor
Bayer Plc (UK)
Enrollment
200
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 18, 2008
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Bayer Plc (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Atrial fibrillation patients newly referred for, and accepting of, anticoagulant therapy
  • 2\. Aged 18 years or older, either sex

Exclusion Criteria

  • 1\. Aged less than 18 years old
  • 2\. Have any contraindication to warfarin or have previously received warfarin
  • 3\. Have valvular heart disease
  • 4\. Are cognitively impaired
  • 5\. Have any disease likely to cause their death within 12 months

Outcomes

Primary Outcomes

Not specified

Similar Trials